Crinetics Pharmaceuticals, Inc. (CRNX)

Crinetics Pharmaceuticals Revenue

Crinetics Pharmaceuticals had revenue of $10.73M in the quarter ending March 31, 2026, with 2,873.41% growth. This brings the company's revenue in the last twelve months to $18.07M, up 2,277.50% year-over-year. In the year 2025, Crinetics Pharmaceuticals had annual revenue of $7.70M with 640.71% growth.

• Revenue (ttm): $18.07M
• Revenue Growth: +2,277.50%
• P/S Ratio: 214.57
• Revenue / Employee: $30,419
• Employees: 594
• Market Cap: 3.88B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	7.70M	6.66M	640.71%
Dec 31, 2024	1.04M	-2.97M	-74.11%
Dec 31, 2023	4.01M	-724.00K	-15.28%
Dec 31, 2022	4.74M	3.66M	339.42%
Dec 31, 2021	1.08M	1.01M	1,418.31%
Dec 31, 2020	71.00K	-1.12M	-94.05%
Dec 31, 2019	1.19M	-1.24M	-50.86%
Dec 31, 2018	2.43M	383.00K	18.73%
Dec 31, 2017	2.05M	1.46M	247.20%
Dec 31, 2016	589.00K	-	-

Data Source: Fiscal.ai Last updated: May 7, 2026

Revenue data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 15, 2026

Data Sources Report a data error